The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Abstract
Drug resistance in tuberculosis (TB) is a particular problem because the lengthy therapy of at least 6 months makes patient compliance very difficult, which frequently creates drug-resistant strains of Mycobacterium tuberculosis . This chapter provides an update on genes associated with drug resistance and the current understanding of mechanisms of drug resistance and drug action in M. tuberculosis . The emergence of drug resistance in bacteria is one of the easiest demonstrations of the "survival of the fittest" concept of Darwin's theory of evolution. Resistance is thus due to a change in the genotype resulting in a drug-resistant phenotype of a bacterium, which can be passed on to subsequent generations. This is in contrast to tolerance, or phenotypic resistance, another phenomenon that is common to M. tuberculosis and other bacterial species, in which changes in the metabolic or physiological status of the cell induce temporary drug resistance as seen in stationary-phase, starved, or dormant bacteria. Knowledge about the mutations conferring drug resistance not only leads to understanding of the mechanisms of drug resistance and drug action but also facilitates rapid detection of drug resistance by molecular means. Phenotypic resistance is a major problem for antibiotic therapy, especially for TB. Nongrowing bacteria can be divided roughly into two different types depending on whether they grow immediately on subculture into a defined fresh medium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 11×
“Resistance to INH occurs more frequently than for most anti-tuberculosis drugs, at a frequency of 1 in 105–6 bacilli in vitro.47 INH-resistant clinical isolates of M. tuberculosis often lose catalase and peroxidase enzyme48 encoded by katG, especially in highlevel resistant strains (MIC > 5 μg/ml).47 Low-level resista…”
BackgroundResultInfluentialSelf-citationDetection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Self-citationBass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., & Thornton, G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,193
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
INFECTIVE HEREDITY OF MULTIPLE DRUG RESISTANCE IN BACTERIA
Watanabe, T. (1963) · Bacteriological Reviews · doi:10.1128/br.27.1.87-115.1963 · Cited by 865
Okusu, H., Ma, D., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.306-308.1996 · Cited by 814
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Self-citationJin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Self-citationMolecular Koch's Postulates Applied to Microbial Pathogenicity
Falkow, S. (1988) · Clinical Infectious Diseases · doi:10.1093/cid/10.supplement_2.s274 · Cited by 655
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Wilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
M. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
The action of antituberculosis drugs in short-course chemotherapy
Mitchison, D. A. (1985) · Tubercle · doi:10.1016/0041-3879(85)90040-6 · Cited by 518
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Self-citationZhang, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg446 · Cited by 477
Self-citationSTREPTOMYCIN, SUPPRESSION, AND THE CODE
Davies, J., Gilbert, W., & Gorini, L. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.883 · Cited by 474
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Self-citationBelanger, A. E., Besra, G. S., Ford, M. E., Mikusová, K., Belisle, J. T., Brennan, P. J., & Inamine, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11919 · Cited by 466
Observations on the Mechanism of Action of Penicillin.
Hobby, G. L., Meyer, K., & Chaffee, E. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-50-13773 · Cited by 444
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Cell Genetics and Hereditary Symbiosis
Lederberg, J. (1952) · Physiological Reviews · doi:10.1152/physrev.1952.32.4.403 · Cited by 387
Bifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Finken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Goodwin, A., Kersulyte, D., Sisson, G., Veldhuyzen van Zanten, S. J. O., Berg, D. E., & Hoffman, P. S. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00806.x · Cited by 353
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Self-citationCharacterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
Scorpio, A., Lindholm-Levy, P., Heifets, L., Gilman, R., Siddiqi, S., Cynamon, M., & Zhang, Y. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.540 · Cited by 333
Self-citationHeym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Cohen, S. P., Levy, S. B., Foulds, J., & Rosner, J. L. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.24.7856-7862.1993 · Cited by 329
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
Permeability barrier to hydrophilic solutes in Mycobacterium chelonei
Jarlier, V, & Nikaido, H. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.3.1418-1423.1990 · Cited by 315
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
On the mechanism of rifampicin inhibition of RNA synthesis.
McClure, W. R., & Cech, C. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34269-2 · Cited by 310
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
Mutations in Putative Mutator Genes of Mycobacterium tuberculosis Strains of the W-Beijing Family
Ebrahimi-Rad, M., Bifani, P., Martin, C., Kremer, K., Samper, S., Rauzier, J., Kreiswirth, B., Blazquez, J., Jouan, M., van Soolingen, D., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020803 · Cited by 288
ethA , inhA , and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates
Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T., & Cooksey, R. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3799-3805.2003 · Cited by 288
Zhang, Y., Scorpio, A., Nikaido, H., & Sun, Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2044-2049.1999 · Cited by 285
Self-citationAltered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
Self-citationVilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4059-4067.2000 · Cited by 283
Self-citationJohnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
Pym, A. S., Saint-Joanis, B., & Cole, S. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4955-4960.2002 · Cited by 278
Wolucka, B. A., McNeil, M. R., de Hoffmann, E., Chojnacki, T., & Brennan, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31657-5 · Cited by 272
Zimhony, O., Cox, J. S., Welch, J. T., Vilchèze, C., & Jacobs, W. R. (2000) · Nature Medicine · doi:10.1038/79558 · Cited by 270
Self-citationHeym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Self-citationMcCune, R. M., & Tompsett, R. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.104.5.737 · Cited by 260
Kremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R., Brennan, P. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000569200 · Cited by 256
Self-citationSchatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 251
Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis
Billington, O. J., McHugh, T. D., & Gillespie, S. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1866 · Cited by 251
Mycobacterium tuberculosis Beijing Genotype Emerging in Vietnam
Anh, D. D., Borgdorff, M. W., Van, L. N., Lan, N. T. N., van Gorkom, T., Kremer, K., & van Soolingen, D. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0603.000312 · Cited by 249
Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., & Musser, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.326-336.2000 · Cited by 240
Marrakchi, H., Lanéelle, G., & Quémard, A. (2000) · Microbiology · doi:10.1099/00221287-146-2-289 · Cited by 238
Whiteway, J., Koziarz, P., Veall, J., Sandhu, N., Kumar, P., Hoecher, B., & Lambert, I. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.21.5529-5539.1998 · Cited by 237
Williams, D. L., Spring, L., Collins, L., Miller, L. P., Heifets, L. B., Gangadharam, P. R. J., & Gillis, T. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1853 · Cited by 236
The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase
Vannelli, T. A., Dykman, A., & Ortiz de Montellano, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110751200 · Cited by 232
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S., Bai, G. H., Suffys, P., Portillo-Gomez, L., Fairchok, M., & Rouse, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 231
Transposition of an antibiotic resistance element in mycobacteria
Martin, C., Timm, J., Rauzier, J., Gomez-Lus, R., Davies, J., & Gicquel, B. (1990) · Nature · doi:10.1038/345739a0 · Cited by 222
Mycobacterial porins – new channel proteins in unique outer membranes
Niederweis, M. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03662.x · Cited by 221
Delihas, N., & Forst, S. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5029 · Cited by 220
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Self-citationMechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Action Mechanism of Antitubercular Isoniazid
Lei, B., Wei, C.-J., & Tu, S.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2520 · Cited by 208
Larsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Self-citationTakiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
Self-citationMolecular basis of rifampin resistance in Mycobacterium leprae
Honore, N., & Cole, S. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.414 · Cited by 198
Control Mechanisms for Fatty Acid Synthesis in Mycobacterium Smegmatis
Bloch, K. E. (1977) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122907.ch1 · Cited by 195
Li, Z., Kelley, C., Collins, F., Rouse, D., & Morris, S. (1998) · Journal of Infectious Diseases · doi:10.1086/515254 · Cited by 195
Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia
Krüüner, A., Hoffner, S. E., Sillastu, H., Danilovits, M., Levina, K., Svenson, S. B., Ghebremichael, S., Koivula, T., & Källenius, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3339-3345.2001 · Cited by 190
Takayama, K., Schnoes, H. K., Armstrong, E. L., & Boyle, R. W. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36719-5 · Cited by 185
Buchmeier, N. A., Newton, G. L., Koledin, T., & Fahey, R. C. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03416.x · Cited by 180
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Self-citationSuzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Cheng, S.-J., Thibert, L., Sanchez, T., Heifets, L., & Zhang, Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.528-532.2000 · Cited by 175
Self-citationRole of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets
Dover, L. G., Alahari, A., Gratraud, P., Gomes, J. M., Bhowruth, V., Reynolds, R. C., Besra, G. S., & Kremer, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01063-06 · Cited by 168
Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Infectious Multiple Drug Resistance in the Enterobacteriaceae
Falkow, S. (1975) · doi:10.21236/adb008856 · Cited by 167
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
The effects of salicylate on bacteria
Price, C. T. D., Lee, I., & Gustafson, J. E. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00042-x · Cited by 165
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
Hirano, K., Takahashi, M., Kazumi, Y., Fukasawa, Y., & Abe, C. (1998) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(98)80004-x · Cited by 163
Nair, J., Rouse, D. A., Bai, G., & Morris, S. L. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00924.x · Cited by 163
Johnsson, K., Froland, W. A., & Schultz, P. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2834 · Cited by 160
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 158
Gill, M. J., Simjee, S., Al-Hattawi, K., Robertson, B. D., EASMON, C. S. F., & ISON, C. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2799 · Cited by 158
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Self-citationThe Prodrug Activator EtaA from Mycobacterium tuberculosis Is a Baeyer-Villiger Monooxygenase
Fraaije, M. W., Kamerbeek, N. M., Heidekamp, A. J., Fortin, R., & Janssen, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307770200 · Cited by 153
Boshoff, H. I., Mizrahi, V., & Barry, C. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2167-2172.2002 · Cited by 152
Liu, J., Takiff, H. E., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.13.3791-3795.1996 · Cited by 151
Salfinger, M., & Heifets, L. B. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1002 · Cited by 146
Molenaar, D., van der Rest, M. E., Drysch, A., & Yücel, R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.24.6884-6891.2000 · Cited by 143
Overcoming antimicrobial resistance by targeting resistance mechanisms
Poole, K. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775514 · Cited by 142
Lee, R. E., Jr., Mikušová, K., Brennan, P. J., & Besra, G. S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00153a002 · Cited by 140
Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG
Zahrt, T. C., Song, J., Siple, J., & Deretic, V. P. (2001) · Molecular Microbiology · doi:10.1111/j.1365-2958.2001.02321.x · Cited by 140
Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0231 · Cited by 139
Fitness of antibiotic-resistant microorganisms and compensatory mutations
Böttger, E. C., Springer, B., Pletschette, M., & Sander, P. (1998) · Nature Medicine · doi:10.1038/3906 · Cited by 138
EFFECT OF ISONICOTINIC ACID HYDRAZIDE ON DIPHOSPHOPYRIDINE NUCLEOTIDASES
Zatman, L. J., Kaplan, N. O., Colowick, S. P., & Ciotti, M. M. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65473-0 · Cited by 135
Quan, S., Venter, H., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2456 · Cited by 135
The Chemical Approach to the Control of Tuberculosis
FOX, H. H. (1952) · Science · doi:10.1126/science.116.3006.129 · Cited by 134
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 133
Self-citationGuillemin, I., Jarlier, V., & Cambau, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2084 · Cited by 132
Heinz, U., Hegetschweiler, Κ., Acklin, P., Faller, B., Lattmann, R., & Schnebli, H. P. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17<2588::aid-anie2588>3.0.co;2-8 · Cited by 131
Heym, B., Stavropoulos, E., Honoré, N., Domenech, P., Saint‐Joanis, B., Wilson, T. M., Collins, D. M., Colston, M. J., & Cole, S. T. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1395-1401.1997 · Cited by 131
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, W. R., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13227 · Cited by 130
Self-citationLee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Agerton, T., Valway, S. E., Blinkhorn, R., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520187 · Cited by 127
Saint‐Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M., & Cole, S. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380753 · Cited by 126
Werngren, J., & Hoffner, S. E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1520-1524.2003 · Cited by 126
Rosner, J. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8771 · Cited by 123
Bodmer, T., Zürcher, G., Imboden, P., et al. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.345 · Cited by 123
The Role of Pyrazinamide in Tuberculosis Chemotherapy
Steele, M. A., & Prez, R. M. D. (1988) · CHEST Journal · doi:10.1378/chest.94.4.845 · Cited by 120
Buchmeier, N. A., & Fahey, R. C. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00441.x · Cited by 119
Permeability Barrier to Rifampin in Mycobacteria
Hui, J., Gordon, N. C., & Kajioka, R. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.773 · Cited by 117
Slayden, R. A., & Barry, C. E. (2002) · Tuberculosis · doi:10.1054/tube.2002.0333 · Cited by 115
Haas, W., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, P. B., Bretzel, G., Sticht-Groh, V., & Bremer, H. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1601 · Cited by 115
Mdluli, K. E., Sherman, D. R., Hickey, M. J., Kreiswirth, B. N., Morris, S. L., Stover, C. K., & Barry, C. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1085 · Cited by 112
Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis
Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D. J., & Amaral, L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2804-2810.2002 · Cited by 110
Mycobacterium phlei Fatty Acid Synthetase—A Bacterial Multienzyme Complex
Brindley, D. N., Matsumura, S., & Bloch, K. E. (1969) · Nature · doi:10.1038/224666a0 · Cited by 109
Владиславович, М. И., Otten, T., Vyshnevskiy, B. I., & Narvskaya, O. V. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3810-3813.2002 · Cited by 109
Wengenack, N. L., Uhl, J. R., Amand, A. L. S., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R., & Rusnak, F. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514096 · Cited by 108
Cooksey, R. C., Morlock, G. P., McQueen, A., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1186 · Cited by 107
Molecular determinants of drug resistance in tuberculosis.
Riska, P. F., Jacobs, W. R., & Alland, D. (2000) · PubMed · Cited by 106
Self-citationCrystal Structure and Mechanism of Catalysis of a Pyrazinamidase from Pyrococcus horikoshii
Du, X., Wang, W., Kim, R., Yakota, H., Nguyen, H., & Kim, S. (2001) · Biochemistry · doi:10.1021/bi0115479 · Cited by 105
Wilson, T. M., de Lisle, G. W., Marcinkeviciene, J. A., Blanchardand, J. S., & Collins, D. M. (1998) · Microbiology · doi:10.1099/00221287-144-10-2687 · Cited by 105
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation
Dabbs, E. R., Yazawa, K., Mikami, Y., Miyaji, M., Morisaki, N., Iwasaki, S., & FURIHATA, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.1007 · Cited by 101
Middlebrook, G. (1952) · PubMed · Cited by 100
Taniguchi, H., Chang, B., Abe, C., Nikaido, Y., Mizuguchi, Y., & Yoshida, S. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4795-4801.1997 · Cited by 91
Quémard, A., Dessen, A., Sugantino, M., Jacobs, W. R., Sacchettini, J. C., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja950998b · Cited by 90
Self-citationWei, C., Lei, B., Musser, J. M., & Tu, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.670-675.2003 · Cited by 89
Nguyen, M., Quémard, A., Broussy, S., Bernadou, J., & Meunier, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2137-2144.2002 · Cited by 86
Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D., van Helden, P. D., & Sim, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02648.x · Cited by 86
Pagán-Ramos, E., Song, J., McFalone, M., Mudd, M. H., & Deretic, V. P. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.18.4856-4864.1998 · Cited by 85
Scorpio, A., Collins, D., Whipple, D. L., Cave, D., Bates, J. H., & Zhang, Y. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.106-110.1997 · Cited by 85
Self-citationYu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
Kremer, L., Dover, L. G., Morbidoni, H. R., Vilchèze, C., Maughan, W. N., Baulard, A. R., Tu, S., Honoré, N., Deretic, V. P., Sacchettini, J. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302435200 · Cited by 81
Self-citationAnaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis
Wade, M. M., & Zhang, Y. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45639-0 · Cited by 80
Self-citationNovel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis
Honoré, N., Marchal, G., & Cole, S. T. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.769 · Cited by 77
Nachamkin, I., Kang, C., & Weinstein, M. P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.894 · Cited by 76
Tarshis, M. S., & WEED, W. A. (1953) · PubMed · doi:10.1164/art.1953.67.3.391 · Cited by 74
Lety, M. A., Nair, S., Berche, P., & Escuyer, V. E. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2629 · Cited by 72
Bakonytė, D., Baranauskaite, A., Cicenaite, J., Sosnovskaja, A., & Stakėnas, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.2009-2011.2003 · Cited by 69
RifR mutations in the beginning of the Escherichia coli rpoB gene
Severinov, K., Soushko, M., Goldfarb, A., & Nikiforov, V. (1994) · Molecular and General Genetics MGG · doi:10.1007/bf00283512 · Cited by 68
Kwon, D. H., Kato, M., El-Zaatari, F. A., Osato, M. S., & Graham, D. Y. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00235-4 · Cited by 67
Mycobacterium smegmatis d -Alanine Racemase Mutants Are Not Dependent on d -Alanine for Growth
Chacón, O., Feng, Z., Harris, N., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.47-54.2002 · Cited by 66
Susceptibility of Mycobacterium tuberculosis to weak acids
Zhang, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg287 · Cited by 63
Self-citationPhenotypic and Genotypic Characterization of Mycobacterium africanum Isolates from West Africa
Frothingham, R., Strickland, P. L., Bretzel, G., Ramaswamy, S. V., Musser, J. M., & Williams, D. L. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1921-1926.1999 · Cited by 62
Role of Superoxide in Catalase-Peroxidase-Mediated Isoniazid Action against Mycobacteria
Wang, J., Burger, R. M., & Drlica, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.709 · Cited by 60
Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds.
MUSTAEV, A. A., ZAYCHIKOV, E. F., Severinov, K. V., Kashlev, M., Polyakov, A., Nikiforov, V., & Goldfarb, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12036 · Cited by 59
Loss of oxyR in Mycobacterium tuberculosis
Deretic, V. P., Song, J., & Pagán-Ramos, E. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01112-8 · Cited by 58
Iron enhances the antituberculous activity of pyrazinamide
Somoskövi, Á. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh042 · Cited by 58
Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Bulatović, V. M., Wengenack, N. L., Uhl, J. R., Hall, L., Roberts, G. D., Cockerill, F. R., & Rusnak, F. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2765-2771.2002 · Cited by 56
Characterization ofpncAMutations of Pyrazinamide-ResistantMycobacterium tuberculosisin Korea
Lee, K. W., Lee, J. M., & Jung, K. S. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.5.537 · Cited by 55
Boshoff, H. I., & Mizrahi, V. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5809-5814.1998 · Cited by 52
Payton, M. A., Schartau, P., Hagemeier, C. H., Lucas, S. J., Mushtaq, A., Gifford, C., Pintér, K., & Sim, E. (2001) · Microbiology · doi:10.1099/00221287-147-12-3295 · Cited by 50
Hou, L., Osei‐Hyiaman, D., Zhang, Z., Wang, B., YANG, A., & KANO, K. (2000) · Epidemiology and Infection · doi:10.1017/s0950268899003635 · Cited by 48
Kenney, T. J., & Churchward, G. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.19.6153-6156.1994 · Cited by 39
Winder, F. G., Collins, P., & Rooney, S. A. (1970) · Biochemical Journal · doi:10.1042/bj1170027pa · Cited by 36
Salicylate Reduces Susceptibility of Mycobacterium tuberculosis to Multiple Antituberculosis Drugs
Schaller, A., Sun, Z., Yang, Y., Somoskövi, Á., & Zhang, Y. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2636-2639.2002 · Cited by 35
Self-citationStrain variation in the katG region of Mycobacterium tuberculosis
Zhang, Y., & Young, D. B. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01291.x · Cited by 34
Self-citationMcDermott, P. F., White, D. G., Podglajen, I., et al. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.11.2995-2998.1998 · Cited by 33
Broussy, S., Coppel, Y., Nguyen, M., Bernadou, J., & Meunier, B. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204637 · Cited by 27
Dubnau, E., Soares-Appel, S., Huang, T. J., & Jacobs, W. R. (1996) · Gene · doi:10.1016/0378-1119(95)00841-1 · Cited by 12
Self-citation
Cited by
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., Wang, H., Zhang, W., & Zhang, Y. (2011) · Science · doi:10.1126/science.1208813 · Cited by 514
Self-citationRapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Coll, F., McNerney, R., Preston, M. D., Guerra-Assunção, J. A., Warry, A., Hill-Cawthorne, G., Mallard, K., Nair, M., Miranda, A., Alves, A., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0164-0 · Cited by 420
Recent updates on drug resistance in Mycobacterium tuberculosis
Singh, R., Dwivedi, S. P., Gaharwar, U. S., Meena, R., Rajamani, P., & Prasad, T. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14478 · Cited by 337
Seifert, M., Catanzaro, D., Catanzaro, A., & Rodwell, T. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119628 · Cited by 326
Metadata
- Authors
- Zhang, Y., Vilchèze, C., & Jacobs, W. R.
- Venue
- Tuberculosis and the Tubercle Bacillus
- Publisher
- Wiley
- Published
- 2004-12-13
- Volume
- 13
- Issue
- 11
- Pages
- 115-140
- OpenAlex
- W1494220503
- Cited by
- 261
- References
- 173
- Type
- other
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.